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Insulin signaling is central to cellular metabolism and organismal aging. However, the role
of insulin signaling in natural and proteotoxically stressed aging neurons has yet to be
fully described. We studied aging of Caenorbaditis elegans mechanosensory neurons
expressing a neurotoxic expanded polyglutamine transgene (polyQ128), or lacking this
proteotoxicity stressor (polyQ0), under conditions in which the insulin signaling pathway
was disrupted by RNA interference (RNAi). We describe specific changes in lifespan,
mechanosensory neuronal morphologies, and mechansensory function following RNAi
treatment targeting the insulin signaling pathway. Overall, we confirmed that transcription
factor DAF-16 is neuroprotective in the proteotoxically stressed model, though not
strikingly in the naturally aging model. Decreased insulin signaling through daf-2 RNAi
improved mechanosensory function in both models and decreased protein aggregation
load in polyQ128, yet showed opposing effects on accumulation of neuronal aberrations
in both strains. Decreased daf-2 signaling slightly enhanced mechanosensation while
greatly enhancing branching of the mechanosensory neuron axons and dendrites in
polyQ0 animals, suggesting that branching is an adaptive response in natural aging.
These effects in polyQ0 did not appear to involve DAF-16, suggesting the existence of
a non-canonical DAF-2 pathway for the modulation of morphological adaptation. However,
in polyQ128 animals, decreased daf-2 signaling significantly enhanced mechanosensation
while decreasing neuronal aberrations. Unlike other interventions that reduce the strength
of insulin signaling, daf-2 RNAi dramatically redistributed large polyQ128 aggregates to
the cell body, away from neuronal processes. Our results suggest that insulin signaling
strength can differentially affect specific neurons aging naturally or under proteotoxic
stress.
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INTRODUCTION
The insulin/insulin-like growth factor (IGF) signaling path-
way is involved in longevity and stress response across species
(Broughton and Partridge, 2009). Signaling through this evo-
lutionarily conserved pathway can promote longevity through
increased expression of cellular stress and metabolism genes,
including those encoding stress-response, chaperone, and antiox-
idant proteins (Kenyon, 1993; Hsu et al., 2003; Taguchi et al.,
2007; Cohen et al., 2009). The progression of neurodegenera-
tive disorders, such as Huntington’s, Alzheimer’s, and Parkinson’s
diseases, has been linked to insulin signaling in both inver-
tebrate and mammalian model systems (Dillin and Cohen,
2011). In addition, decreased insulin signaling has protective
effects against neurodegenerative-associated proteotoxicity across
species (Freude et al., 2009; Killick et al., 2009).
The Caenorhabditis elegans insulin signaling pathway is reg-
ulated by insulin-like signaling ligands, INS-1 through INS-39,
that modulate the activity of the DAF-2 tyrosine kinase receptor
(Figure 1). DAF-2 is orthologous to the mammalian insulin/IGF
receptor. This receptor activates a protein kinase signaling path-
way, which, through phosphorylation of downstream transcrip-
tion factor DAF-16 by AKT protein kinase, regulates functions
similar to receptor kinases in the insulin signaling pathway in
humans. Under high signaling conditions, DAF-16 is phospho-
rylated to prevent nuclear entry and hence transcription. Under
low signaling conditions, DAF-16 is free from inhibitory phos-
phorylation and can regulate the expression of many different
genes contributing to metabolism and physiological defense and
homeostasis responses (Mukhopadhyay et al., 2006). This insulin
signaling pathway has many branch points, including AKT, and
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FIGURE 1 | The insulin signaling pathway in Caenorhabditis elegans.
Upon insulin ligand binding to the DAF-2 insulin receptor in C. elegans,
AGE-1 (homolog to mammalian PI3-K) is activated and converts PIP2 to PIP3
at the cellular membrane. PIP3 activates the central kinase AKT-1 (ortholog
to mammalian PKB), which phosphorylates DAF-16, the C. elegans FOXO
transcription factor, preventing its entry into the nucleus where it would
otherwise regulate the expression of genes contributing to longevity, stress
response, and metabolism. The DAF-18 (homolog to mammalian PTEN)
phosphatase negatively regulates the system by decreasing the amount of
PIP3 present at the membrane by reconverting it to PIP2.
there is some variation in the identities of proteins involved in
nematodes, flies, and mice, three organisms in which the role of
insulin signaling in aging has been investigated. Nevertheless, this
central, conserved insulin signaling pathway is critical for appro-
priate cellular metabolism andmaintenance of overall organismal
health.
Various mutations in genes modulating the C. elegans insulin
signaling pathway have been shown to directly regulate lifespan.
For example, daf-2 insulin receptor mutants live twice as long as
wildtype animals (Kenyon, 1993), age-1 PI3K mutants live longer
than wildtype animals (Friedman and Johnson, 1988), and the
lack of the daf-16 FOXO transcription factor gene shortens lifes-
pan (Oh et al., 2006). Longevity effects can result from limiting
insulin signaling in only the neurons or intestinal cells (Libina
et al., 2003). In mammals, the effect of reduced insulin signaling
on overall health and lifespan is complex, but combined evidence
from many studies points to the potential of insulin signaling
reduction to extend lifespan (Taguchi and White, 2008). In mice,
reduced neuronal or whole animal expression of IRS2, a kinase
activated by the insulin receptor, increases lifespan (Taguchi et al.,
2007). In humans, various studies have detected an association
between longevity and single nucleotide polymorphisms in genes
involved in insulin signaling, including the DAF-16-related tran-
scription factor inhibited by insulin signaling (FOXO3A), the
insulin receptor (IGF1R), and a central protein kinase (AKT-1)
(Newman and Murabito, 2013). Excellent reviews comparing
insulin signaling in various model systems have been published
(Taguchi and White, 2008; Broughton and Partridge, 2009; Neri,
2012).
C. elegans exhibit many important neuronal components
found in humans, including, but not limited to, neurotrans-
mitters, ligand receptors, and ion channels; thus, these animals
are a powerful model for studying neuronal aging and neu-
rodegeneration in vivo. Neurodegenerative disorders, such as
Huntington’s, Alzheimer’s, and Parkinson’s diseases, result in the
progressive loss of structure and function of neurons with age. Of
these protein aggregation-associated neurodegenerative diseases,
Huntington’s disease is caused by the expansion of CAG trinu-
cleotide repeats in the huntingtin gene, which results in an expan-
sion of the length of polyglutamine residues at the N-terminus
of the huntingtin protein. Expanded polyglutamine repeats in
mutated huntingtin lead to neuronal protein aggregation, impair-
ments in movement and cognitive function, and psychological
disorders. Multiple Huntington’s disease model strains of C. ele-
gans have been developed (Faber et al., 1999; Parker et al., 2001,
2005; Morley et al., 2002). In the model strain used in this
study, touch-receptor neuron-specific expression of a transgene
encoding the first 57 amino acids of human huntingtin with 128
polyglutamine repeats impairs function, without neuronal death
(Parker et al., 2001, 2005). Thus, this model may feature con-
served events associated with dysfunction that typify early disease
stages in humans.
Aging is the primary risk factor formultiple neurodegenerative
diseases, yet the intersection of natural neuronal aging and neu-
rodegenerative states is not well understood. As a consequence
of sensing and responding to the environment, the nervous sys-
tem is known to play a role in physiological aging (Alcedo et al.,
2013). In normal, healthy aging, C. elegans mechanosensory and
other neuron classes develop morphological aberrations, includ-
ing new outgrowths from the soma, novel process branching, and
dendritic restructuring (Pan et al., 2011; Tank et al., 2011; Toth
et al., 2012). Neuronal insulin signaling appears to be involved
in this natural aging process; the link between normal aging
and decline under disease conditions is relatively unexplored. To
address this relationship, we studied and compared morphologi-
cal features of aging mechanosensory neurons with and without
a neurotoxic expanded polyglutamine transgene, under condi-
tions in which genes of the canonical insulin signaling pathway
were disrupted by neuron-targeted RNA interference (RNAi).
Our findings suggest that insulin signaling strength can differen-
tially affect specific neurons aging naturally or under conditions
of disrupted proteostasis. Under conditions of polyglutamine
expansion stress, insulin receptor DAF-2 appears to act through
DAF-16/FOXO. However, under conditions of normal aging,
DAF-2 activates a non-canonical pathway that acts independently
to induce neuroprotection.
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MATERIALS AND METHODS
STRAINS
The C. elegans Huntington’s disease model strain used was
derived from two previously engineered strains. Strain ID1 (igls1
[Pmec-7yfp, Pmec-3htt57Q128::cfp, lin-15(+)]) (polyQ128) con-
tains the first 57 amino acids of human huntingtin fused to
CFP-labeled expanded polyglutamine tract (Q128) expressed
in the 6 mechanosensory neurons as well as in PVD and
FLP neurons (Parker et al., 2001). These polyQ128 animals
show functional deficiencies in touch response and accumula-
tion of huntingtin protein aggregates in mechanosensory neu-
rons, without cell death (Parker et al., 2001). Strain TU3270
(uIs57 [Punc-119SID-1, Punc-119yfp, Pmec-6mec-6]) overexpresses
the transmembrane channel SID-1 pan-neuronally, allowing the
dsRNA from RNAi treatment to enter all neurons (Calixto
et al., 2010). TU3270 and ID1 were crossed to generate
ZB4062 igIs1[Pmec-7yfp, Pmec-3htt57Q128::cfp, lin-15(+)]; uIs57
[Punc-119SID-1, Punc-119yfp, Pmec-6mec-6], a polyQ128-expressing
strain with neurons susceptible to RNAi.We also crossed a healthy
transgenic model, ZB154 (zdIs5 [Pmec-4GFP, lin-15(+)]), to
TU3270 to generate ZB4064 zdIs5 [Pmec-4GFP, lin-15(+)]; uIs57
[Punc-119SID-1, Punc-119yfp, Pmec-6mec-6] to render mechanosen-
sory neurons susceptible to RNAi treatment (polyQ0).
WORMMAINTENANCE
Standard methods were used for strain maintenance, bacterial
culturing, and animal manipulation (Brenner, 1974). Stock ani-
mals were cultured at room temperature (about 22◦C) on nema-
tode growth media (NGM) agar plates seeded with live bacteria
(E. coli strain OP50-1).
RNA INTERFERENCE TREATMENTS
We prepared RNAi plates using 4× concentrated live HT115
E. coli bacteria from the Ahringer Library induced at room tem-
perature for 2 days on agar plates. For each batch of RNAi
experiments, we performed a control experiment comparing
the amount of nerve ring fluorescence knockdown following
GFP treatment to empty vector (L4440) in age-matched ani-
mals to confirm neuronal RNAi sensitivity of the strain used
(Supplemental Figure 1). Only experiments that showed a sig-
nificant (unpaired t-test, p < 0.05) knockdown of GFP were
used for further RNAi studies. We performed RNAi treatments
at 25◦C protected from light with age-synchronous popula-
tions created using timed egg lay. To perform each egg lay,
adult worms laid eggs on each of the described RNAi treatment
plates for 4 h. Animals in all RNAi experiments were trans-
ferred by hand each day of adulthood to fresh RNAi plates.
We performed and analyzed RNAi experiments “blinded” to
the intervention so that the experimenter was not aware of
the genetic identity of the RNAi treatment given to each pop-
ulation of animals. We repeated each experiment at least 3
times. We selected day 5 of adulthood as a time point for
analysis in the following experiments based on Toth et al.
(2012) who reported a significant difference in mechanosen-
sory neuronal morphology between day 1 and day 5 of
adulthood.
LIFESPAN ANALYSIS
Following the production of age-synchronous populations, we
transferred approximately 50 animals from each RNAi treatment
group everyday of adulthood to fresh, seeded RNAi treatment
small plates and checked for survival by visual observation or
gentle prodding with a platinum wire. Animals with protrud-
ing intestines, those that bore live young, or that crawled off
the plates were censored. Survival experiments always included
all 6 RNAi treatment groups (L4440 empty vector, daf-2, age-
1, daf-18, akt-1, daf-16) at once for, usually, one strain at a
time, and were repeated at least twice. We used Kaplan–Meier
log-rank survival statistics to analyze differences in mean sur-
vival between RNAi treatment groups and p < 0.05 was noted as
significant.
MECHANOSENSORY RESPONSE ASSAY
We generated synchronous populations as described above, main-
tained cultures at 25◦C, and transferred each day of adulthood to
fresh RNAi treatment plates. On day 5 of adulthood we scored
individuals for motility class. Individuals were grouped into 3
classes: A class indicates normal, voluntary sinusoidal move-
ment, B class indicates locomotion following gentle prodding,
and C class indicates inability to locomote. We then tested indi-
viduals for their ability to respond to touch by gently touching
alternatively on the anterior and posterior end with an eye-
lash pick, 5 times each (Figure 2B). Animals responded either
by moving (or attempting to move) in the opposite direction
of the touch or by showing no movement. We scored animals
(0–5) based on the number of positive responses to touch out
of 5 touches at the anterior and 5 touches at the posterior. We
also recorded the mobility of each animal. We then imaged the
mechanosensory neurons of the tested individuals as described
below.
NEURONAL MORPHOLOGY IMAGING
Following the mechanosensory response assay on day 5 of
adulthood, we mounted animals between 2 cover slips using
2μL of 36% w/v Pluronic™ solution dissolved in water and
imaged using the 20× objective of an Axiovert S100 inverted
fluorescent microscope. Using constant microscope settings, we
collected images of the 6 mechanosensory neurons of each
individual and their associated huntingtin protein aggregates,
if present, using FITC and CFP filters, respectively. We dis-
carded animals after imaging, so data presented is cross-sectional
rather than longitudinal. We repeated mechanosensory response
assays and neuronal morphology imaging for each strain and
RNAi treatment group at least 3 times. We examined the
images of 6 mechanosensory neurons of each individual for
morphological aberrations, namely cell body outgrowths, cell
body guidance errors, and process branching (Toth et al.,
2012).
PROTEIN AGGREGATE QUANTIFICATION AND DATA ANALYSIS
For polyQ128 experiments, we analyzed huntingtin aggregates
(fused with CFP) with ImageJ, using a custom macroinstruc-
tion that includes quantification of the total area of aggregates
seen in each cell. For comparisons of mechanosensory response
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FIGURE 2 | PolyQ0 and polyQ128 exhibit basal differences in
mechanosensory neuron morphology and function without altered
lifespan. (A) Kaplan–Meier survival curves for one representative survival
experiment shown for empty vector (L4440) treated polyQ0 and polyQ128
animals. Mean and median lifespan do not differ between the two strains.
(B) Schematic of posterior touch test; an animal is touched at the tail and
normally moves forward, gaining 1 positive response to touch (out of 5). For
anterior touch test, animals are touched at the head and scored for backwards
movement. Mechanosensory neurons (PLMs and ALMs) and pharynx shown.
(C) Anterior and posterior touch test scores for empty vector control
individuals. Each bar represents the mean number of positive responses out of
5 to soft touch. (D) Total number of aberrations (e.g., number of outgrowths
and branches and presence of abnormal cell body and punctae) per worm and
cell type for each empty vector control group. Whole worm bars represent the
mean values of the sum of all 4 neurons scored (ALML, ALMR, PLML, and
PLMR) for each individual. Anterior and posterior bars represent the mean
values for individual anterior (ALML or ALMR) or posterior (PLML or PLMR)
neurons. ∗Denotes significance of p < 0.01 and #denotes significance of
p < 0.10 following Mann–Whitney U comparison. Each bar shows mean ± SE
for N = 69 (polyQ0) and N = 84 (polyQ128) animals.
and neuronal morphology between empty vector control polyQ0
and polyQ128 strains, we used a Mann–Whitney U comparison.
For the mechanosensory response assays, neuronal morphology
imaging, and protein aggregate counts following RNAi treat-
ments, we used a generalized linear model with a log link function
(Poisson regression) and Wald tests for significance of treat-
ment effects. For total aggregate area measurements, we used
a One-Way ANOVA with Tukey’s pairwise comparisons. SPSS
(Version 20) statistical software was used to perform, the analyses.
A p-value of less than 0.05 was considered statistically signifi-
cant. Values presented in the text represent mean ± standard
error.
RESULTS
NEURON AND SYSTEMIC RNAi KNOCKDOWN OF INSULIN SIGNALING
PROTEINS ALTERS polyQ0 AND polyQ128 C. ELEGANS LIFESPAN
To initiate analysis of the influence of key insulin signaling path-
way genes on normal aging and polyQ128-induced neuronal
deficits in mid-adult life, we constructed C. elegans strains by
genetic crosses with fluorescent mechanosensory (or touch) neu-
ron reporters that express the sid-1 double stranded (ds) RNA
transporter pan-neuronally. This sid-1 compensates for the lack
of a neuronal dsRNA transporter, enabling genes expressed in
neurons to be targeted by RNAi (Calixto et al., 2010). Moreover,
sid-1 overexpression in neurons can diminish non-neuronal RNAi
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effects, such that the sid-1(+) neurons act as a sink for double
stranded RNA (Calixto et al., 2010). We studied one strain that
was free of proteotoxic stress (hereafter referred to as polyQ0),
and one that expresses the first 57 amino acids of human
huntingtin protein with expanded polyglutamines fluorescently
labeled with CFP (polyQ128) (Parker et al., 2001). In these
strains, we can measure neuronal function via mechanosensory
touch response assays, visualize neuronal morphology structures,
and directly observe polyQ128 aggregates. We first confirmed that
polyQ0 and Huntington’s disease model (polyQ128) strain neu-
rons were sensitive to RNAi treatment by feeding as detected
by GFP knockdown in the nerve ring (Supplemental Figure 1).
Indeed, GFP knockdown was efficient in both strains, support-
ing that our intended studies on insulin signaling pathway genes
could effectively target mechanosensory neurons.
Interestingly, healthy polyQ0 and proteotoxically stressed
polyQ128 empty vector (L4440) treated animals exhibited simi-
lar, not significantly different, mean lifespan (Figure 2A). Thus,
increased polyglutamine load in mechanosensory neurons does
not confer decreased lifespan, consistent with previous work
showing mechanosensory neurons are dispensable for viabil-
ity and lifespan (Chalfie et al., 1985). However, empty vector
treated control polyQ128 animals do exhibit signs of abnor-
mal function as measured by motility, touch response, and
accumulation of mechanosensory neuronal aberrations (Table 1,
Figures 2C,D), agreeing with previous work (Parker et al., 2001).
Specifically, polyQ128 posterior touch response is significantly
decreased (Mann–Whitney U, p < 0.01) and neuronal aberra-
tions are increased at the whole worm (Mann–Whitney U, p <
0.01), anterior cells (Mann–Whitney U, p < 0.01), and posterior
Table 1 | Effect of RNAi treatment on polyQ0 and polyQ128 motility.
Strain RNAi treatment Number per Total N
motility class
A B C
polyQ0 Empty vector 65 4 0 69
daf-2 53 0 0 53
age-1 67 4 0 71
daf-18 47 2 0 49
akt-1 50 1 0 51
daf-16 48 3 0 51
polyQ128 Empty vector 69 15 0 84
daf-2 87 6 0 93
age-1 77 18 0 95
daf-18 47 0 0 47
akt-1 31 15 1 47
daf-16 51 20 1 72
Number of individuals falling into A, B, or C class motility for each treatment
group is shown. A class indicates normal, voluntary sinusoidal movement, B
class indicates locomotion following gentle prodding, and C class indicates
inability to locomote. Overall, polyQ128 animals have higher incidence of B
class motility than polyQ0. Only polyQ128 daf-18(RNAi) results in a significant
difference in motility compared to control.
cells level (Mann–Whitney U, p = 0.04) when compared to age-
matched polyQ0 individuals. This suggests that increased polyg-
lutamine load in the mechanosensory neurons negatively affects
the function and healthspan of polyQ128 animals.
Because several previously published mutant and RNAi exper-
iments did not utilize sid-1 enhanced neuronal RNAi targeting,
and thus would not have assayed neuronal knockdown effects, we
also confirmed RNAi effects on longevity under the conditions
we used for our studies. We found that knockdown of insulin
signaling pathway genes in neurons and other tissues altered
healthy polyQ0 life as previously reported, with daf-2, age-1, and
akt-1 RNAi interventions lengthening lifespan, and daf-16 RNAi
shortening it (Figure 3A and Table 2). Insulin signaling path-
way interventions in the polyQ128 strain (daf-2, age-1) similarly
increased mean lifespan, while daf-16 RNAi treatment decreased
mean lifespan (Figure 3B and Table 2). In the 3 biological repli-
cates of akt-1 RNAi in polyQ128 animals, lifespan impact was
variable.
To further address whether there might be differences in gen-
eral viability between polyQ0 and polyQ128 strains, we compared
percent change in mean lifespan between polyQ0 and polyQ128
animals for each RNAi treatment group. We found no significant
differences in relative percent changes between healthy trans-
genic and polyQ128 animals for the same RNAi treatment (t-tests,
p > 0.05), except for daf-16 RNAi, which approached significance
in the polyQ128 background (Figure 3C; p = 0.07). We also
measured endogenous reactive oxygen species (ROS) as detected
by the membrane permeable 2′, 7′-Dichlorofluorescin diacetate
(DCF-DA, Sigma) following RNAi treatments and found that
RNAi treatment targeted at insulin signaling pathway proteins
from embryo did not consistently significantly affect young adult
(day 1) endogenous ROS levels in both healthy transgenic and
polyQ128 strains (data not shown). However, daf-16 RNAi treat-
ment throughmid-life in polyQ128 worms significantly increased
endogenous ROS levels across all biological replicates.
We conclude that RNAi interventions in our polyQ0 and
polyQ128 strains are efficacious and exert similar general influ-
ences on aging biology in polyQ0 and polyQ128 strains.
Disruption of a small set of sensory neurons by the proteotoxic
stress of polyQ128 is not sufficient to grossly impair whole animal
function, although there are some functional impairment and
increased morphological aberrations. However, we note that in
middle-aged adults, daf-16 RNAi is associated with elevated ROS
levels and decreased mid-life viability specifically in the polyQ128
strain, raising the possibility that the combination of small scale
neuronal proteostasis disruption can influence entire organism
decline when DAF-16-dependent defenses are impaired.
DECREASED INSULIN SIGNALING THROUGH RNAi KNOCKDOWN
INFLUENCES HEALTHY MECHANOSENSORY NEURON MORPHOLOGY
AND FUNCTION
Previous studies on morphological aging of mechanosensory
neurons indicated that manipulation of the insulin signaling
pathway can change accumulation of neuronal aberrations (Pan
et al., 2011; Tank et al., 2011; Toth et al., 2012). These studies dif-
fered in details of methods and outcomes, and did not address
akt-1 or daf-18 activities. Moreover, these studies left open the
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FIGURE 3 | Neuronal and systemic insulin signaling mediates lifespan
of both healthy (polyQ0) and proteotoxically stressed (polyQ128)
animals. Kaplan–Meier survival curves for one representative survival
experiment shown for polyQ0 (A) and polyQ128 (B) animals with RNAi
knockdown of the indicated insulin signaling pathway gene. Mean lifespan,
sample size, and significance reported as Replicate 1 for each strain in
(Continued)
FIGURE 3 | Continued
Table 2. (C) Mean percent change in lifespan with RNAi treatment for
polyQ0 and polyQ128 animals pooled across biological replicates. Only
daf-16 RNAi showed a significant impact on lifespan for polyQ128 animals
when compared to polyQ128 empty vector controls (23.3 ± 4.1% for 3
replicates of 45–50 animals). Each bar represents mean ± SE.
question of how morphological features relate to function. To
address these gaps and discrepancies, wemeasured neuronal mor-
phology and touch response as a surrogate for mechanosensory
function when components of the insulin signaling pathway were
knocked down in polyQ0 animals. We performed touch response
tests (Figure 4A) and then imaged mechanosensory neurons of
characterized animals for changes in morphology (Figures 4B,C)
at mid-life (day 5 of adulthood; described in detail in Materials
andMethods). Total neuronal aberrations include all morpholog-
ical aberrations observed in an individual or cell type, including
soma outgrowths, abnormal cell somas, process branching, and
process punctae (Figure 4B).
Our analysis of touch sensory function revealed that both ante-
rior and posterior touch responses in daf-2 RNAi were better than
empty vector at day 5 of adult life (Figure 4A; Wald test, p < 0.01
for anterior and posterior scores). daf-16 RNAi preferentially
decreased posterior touch (p < 0.01), revealing an interesting dif-
ference between anterior and posterior mechanosensory neurons.
We found that RNAi knockdown of age-1, daf-18, and akt-1 did
not alter touch responses as compared to empty vector.
A striking result from our analysis of morphological aberra-
tions at day 5 of adulthood is that daf-2 RNAi increased the
occurrence of total neuronal aberrations as compared to con-
trol (from 3.2 ± 0.23 to 4.7 ± 0.26 per individual) in both
anterior and posterior neurons (Figure 4C). We found that this
increase was driven exclusively by process branching, which was
the only specific neuronal aberration observed to change with
daf-2 RNAi (Figure 4D; from 12.8 ± 3.40 to 32.7 ± 3.80% in
anterior cells and 14.5 ± 3.20 to 39.4 ± 3.70% in posterior cells).
age-1 RNAi also increased total aberrations (from 3.2 ± 0.23 to
4.4 ± 0.23 per individual) (Figure 4C) and novel branching in
anterior neurons (Figure 4D; from 12.8 ± 3.40 to 25.3 ± 3.40%
in anterior cells and 14.5 ± 3.20 to 26.7 ± 3.30% in posterior
cells), whereas daf-18, akt-1, and daf-16 interventions did not
induce statistically significant changes in overall aberrations or in
the hyper-branching phenotype. Our findings suggest that daf-
2 disruption, and lowered insulin signaling could differentially
effect differentmorphologies, and raise the question as to whether
branching might be an indication of a neuroprotective response
(see Discussion).
TOUCH RESPONSE, MECHANOSENSORY NEURONAL MORPHOLOGY,
AND PROTEIN AGGREGATE ACCUMULATION ARE AFFECTED BY
INSULIN SIGNALING IN A MODEL STRAIN OF HUNTINGTON’S DISEASE
PATHOGENESIS
We next examined functionality and morphological aberra-
tions in the polyQ128 strain in which mechanosensory neu-
rons are exposed to a chronic proteotoxic stress that promotes
early dysfunction (Parker et al., 2001). As previously noted,
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Table 2 | Effects of RNAi treatment targeting insulin signaling on polyQ0 and polyQ128 animals’ mean lifespan.
Strain RNAi treatment Replicate 1 Replicate 2 Replicate 3
N Mean lifespan days ± SE N Mean lifespan days ± SE N Mean lifespan days ± SE
polyQ0 Empty vector 50 13.7±0.56 60 14.3±0.58 55 13.5±0.66
daf-2 40 16.8±0.83* N/A N/A 48 16.3±1.04*
age-1 51 16.3±0.82* 59 16.9±0.61* N/A N/A
daf-18 30 11.7±0.70 60 14.8±0.57 50 13.5±0.62
akt-1 40 15.8±0.79* 60 16.2±0.52* 48 13.4±0.50
daf-16 46 11.0±0.61* 60 12.1±0.53* 51 12.9±0.68
polyQ128 Empty vector 50 15.2±0.71 50 15.1±0.61 56 13.4±0.55
daf-2 51 16.1±0.94 50 16.2±0.89* N/A N/A
age-1 40 17.9±1.01* N/A N/A 59 15.0±0.89*
daf-18 38 15.6±0.79 50 14.5±0.66 59 11.4±0.42*
akt-1 47 15.8±0.79 25 14.4±1.15 56 11.4±0.44*
daf-16 48 10.9±0.60* 50 12.8±0.63* 61 10.4±0.39*
Mean lifespan in days ± SE of each RNAi treatment replicate for the polyQ0 and polyQ128 strains are shown. Each replicate of 6 treatments (empty vector control,
DAF-2, AGE-1, DAF-18, AKT-1, and DAF-16) was run one strain at a time. Entries with * are significantly different (p < 0.05) from the strain- and replicate-matched
empty vector control following Kaplan–Meier log-rank survival statistics. Replicate with missing data (N/A) was censored from experiment.
empty vector treated polyQ128 animals exhibit increased aber-
rant neuronal morphology and decreased touch response com-
pared to age-matched, empty vector treated wildtype animals
(Figures 3C,D).
We tested touch response in polyQ128 animals subjected to
RNAi for insulin signaling pathway components (Figure 5A). daf-
2 RNAi had a neuroprotective effect on both anterior (Wald
test, p < 0.001) and posterior touch sensitivity (Wald test,
p < 0.001). Interestingly, however, all other RNAi knockdown
interventions (age-1, daf-18, akt-1, and daf-16) had generally
deleterious effects on touch sensitivity in the polyQ128 back-
ground, with a particularly significant change in posterior touch
response in polyQ128 animals compared with empty vector
(L4440).
We then examined neuronal morphology in the polyQ128
strain following RNAi of the insulin signaling pathway genes
(Figure 5B). We found that numbers of aberrations in the
polyQ128 strain were reduced upon daf-2 RNAi when com-
pared to empty vector (from 4.78 ± 0.21 to 2.94 ± 0.15 per
individual, Wald test, p < 0.001). In contrast, age-1 RNAi, mod-
estly increased aberrations (from 4.3 ± 0.2 to 5.4 ± 0.1 per
individual), as did akt-1 and daf-16 interventions in anterior
mechanosensory neurons. Thus for polyQ128-expressing neu-
rons, morphological aberrations generally inversely correlate with
function: low abnormality abundance corresponds to enhanced
mechanosensory function.
In polyQ128 animals, the huntingtin:polyQ128 protein is
fused with CFP and can be visualized as aggregates in our strain
(Figure 5C). We therefore also examined the number and size
of fluorescent aggregates in mechanosensory neurons following
RNAi knockdown of insulin signaling components (Figure 5D).
Under conditions of daf-2 RNAi we found that mean num-
bers of aggregates were lowered compared to wildtype (Wald
test, p < 0.01 for whole individuals, anterior cells, and poste-
rior cells). Mean aggregate area was unchanged for daf-2 RNAi
(Supplemental Figure 2), suggesting that less aggregated pro-
tein persists in mid-life mechanosensory neurons when DAF-2
signals are reduced. Conversely, we found modest increases in
aggregate number and size for age-1, akt-1, and daf-16 knock-
down (Figure 5D and Supplemental Figure 2). Importantly,
Parker et al. (2005) showed no difference in huntingtin expres-
sion of the polyQ128 animals in age-1 and daf-16 genetic
mutants. This suggests that our findings of altered protein aggre-
gation in the polyQ128 strain is likely not due to changed
huntingtin expression, but rather is more likely attributed
to cellular responses of the expanded polyglutamine protein
(Figure 5).
Interestingly, we noted a striking difference in the localiza-
tion of polyQ128 protein aggregates in posterior and anterior
cells for daf-2 RNAi (Figures 5E,F). In daf-2 RNAi treated ani-
mals, 80–90% of the detected aggregates localized in the cell
body of anterior and posterior cells whereas other insulin sig-
naling pathway knockdowns were associated with a majority
(50–60%) of aggregates localized within the process of these cells,
similar to empty vector controls. We also note that aggregates
were never observed in outgrowths without also being present
in the cell body. This dramatic difference of aggregate localiza-
tion in daf-2 RNAi animals suggests that subcellular distribution
of protein aggregates is regulated by a DAF-2 non-canonical
pathway.
RNAi KNOCKDOWN OF daf-2 RETURNS polyQ128 MECHANOSENSORY
NEURON MORPHOLOGY TO HEALTHY LEVELS
At the whole worm and anterior and posterior cell levels, daf-
2 RNAi knockdown in the neurons of polyQ128 worms lowers
the occurrence of total neuronal aberrations to levels observed
in polyQ0 empty vector treated animals (Wald test, p < 0.01).
However, daf-2 RNAi polyQ128 touch response is still signifi-
cantly lower than polyQ0 empty vector treated animals (Wald
test, p < 0.01).
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FIGURE 4 | daf-2 RNAi mediates mechanosensory neuron morphology
and function in polyQ0 animals. (A) Anterior and posterior touch test
scores of polyQ0 animals following RNAi treatment. Each bar represents
the mean number of positive responses to 5 soft touches.
(B) Representative examples of outgrowths (a), branching (b), punctae (c),
and abnormal cell body (d) phenotypes seen in aging mechanosensory
neurons of polyQ0 and polyQ128 individuals. (C) Mean number of neuronal
aberrations per whole animal (sum of all 4 neurons scored in an individual)
and individual cell type (anterior [ALML or ALMR] and posterior [PLML or
PLMR]). (D) Percentage of neurons with branching phenotype for each
RNAi treatment. Neurons with this phenotype may have more than one
branch (data not shown). (E) Representative images of mechanosensory
neuron processes and process branching (white arrows) in polyQ0 animals.
∗Denotes significance of p < 0.01 and #denotes significance of p < 0.10
relative to appropriate empty vector control following a generalized linear
model with a log link function (Poisson regression) and Wald tests for
significance of treatment effects. Each bar represents mean ± SE for
N = 49–70 animals.
DISCUSSION
SUMMARY OF FINDINGS
To begin to address the relationship between natural and
proteotoxically challenged neuronal aging in a physiological
context, we took advantage of high resolution in vivo anal-
yses of C. elegans mechanosensory neuron morphology and
function. We compared mid-life morphological and functional
features of mechanosensory neurons that aged without, or
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FIGURE 5 | The insulin signaling pathway mediates
mechanosensory neuron morphology and function in polyQ128
animals. (A) Anterior and posterior touch test scores, representing
the number of positive responses to 5 soft touches, following RNAi
treatment for indicated insulin signaling pathway gene of polyQ128
animals. (B) Mean number of neuronal aberrations per whole animal
(sum of all 4 neurons scored in an individual) and individual cell
type (anterior [ALML or ALMR] and posterior [PLML or PLMR]).
(C) Representative image of polyQ128 aggregate (CFP, blue panels)
accumulation within anterior (ALM) and posterior neurons (PLM) (YFP,
green panels). White arrows in YFP panels indicate the location of
the cell body of each neuron. (D) The effect of RNAi treatment on
the number of distinct CFP-labeled extended polyglutatmine huntingtin
protein aggregates in whole animal and anterior and posterior
neurons of polyQ128 animals. (E) Sub-cellular localization of poyQ128
aggregates within anterior neurons of polyQ128 animals that
contained aggregates. (F) Location of polyQ128 aggregates in
posterior neurons of polyQ128 animals. ∗Denotes significance of
p < 0.01 and #denotes significance of p < 0.10 relative to appropriate
empty vector control following generalized linear model analysis with
a log link function (Poisson regression) and Wald tests for
significance of treatment effects. Each bar represents mean ± SE.
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with, the proteotoxic stressor polyQ128, under RNAi condi-
tions that mimic systemic, including neurons, low or high
activation of the insulin signaling pathway. Our data suggest
that insulin signaling plays complex roles in neuronal main-
tenance in both healthy (polyQ0) and degenerate (polyQ128)
neurons, with distinct outcomes on individual neurons notable
even among the similar group of 6 mechanosensory neurons.
Our data on individual neurons highlight remarkable neuronal
diversity of responses to cellular signaling. Comparison of how
the insulin signaling pathway impacts natural and proteotoxic-
associated decline reveals some interesting differences in these two
processes.
We conclude that RNAi down-regulation of the daf-2 insulin
receptor plays a role in morphological aging of mechanosensory
neurons in both normally aging (polyQ0) and proteotoxically
stressed (polyQ128) animals. Anterior and posterior neurons
can be differentially affected by altered neuronal insulin sig-
naling (Table 3). Importantly, our data suggest that decreased
insulin signaling in normally aging systems (polyQ0) actu-
ally enhances some process aberrations in middle aged adults,
with a focused impact on formation of ectopic branches on
axons and dendrites. That daf-2 mechanosensory function is
improved raises the possibility that the structural aberrations
(branching) we observe actually reflect consequences of a defen-
sive response that enhances or protects neuronal health during
aging (Figure 4). age-1 may contribute partially to this pro-
cess in polyQ0 animals, but evidence for the involvement of
other pathway components is not compelling in our study. We
also find that daf-2 RNAi knockdown has distinctive impact
on the proteotoxically stressed polyQ128 mechanosensory neu-
rons: morphological aberrations are lower; and aggregates are
fewer in number and smaller in size, with a striking sub-
cellular restriction of aggregates to the cell body, as com-
pared to empty vector controls. Somewhat surprisingly, other
insulin signaling pathway disruptions have relatively modest
impact on cell function, aggregate morphology, and aggre-
gate distribution in polyQ128 animals; we found that age-
1 RNAi, which extends overall lifespan, did not confer dra-
matic changes in mechanosensory neurons, and often correlated
with daf-16 RNAi in inducing modest effects. Our data raise
the possibility that, under conditions of extreme proteotoxic
stress, neurons utilize a non-canonical daf-2 pathway to enhance
neuroprotection.
EXTENDING UNDERSTANDING OF THE INFLUENCE OF INSULIN
SIGNALING ON HEALTHY AGING MECHANOSENSORY NEURONS
daf-2 insulin receptor
Mechanosensory neuron morphology changes with age in wild-
type animals (Pan et al., 2011; Tank et al., 2011; Toth et al.,
2012). Overall, genetic mutants and systemic RNAi treatments
have suggested that daf-2mutants maintain youthful, aberration-
free phenotypes longer than wildtype animals. Toth et al. (2012)
distinguished among specific abnormality classes to measure
decreases in cell body outgrowths and wavy process pheno-
types, with a trend toward delaying branching in posterior
mechanosensory neurons. Tank et al. (2011) showed that 10
day old daf-2(e1370) mutants had decreased process branching.
Using a neuron-targeted daf-2 RNAi approach, we measured an
increase in neuronal aberrations at day 5 of adulthood, the vast
majority of which are novel branches (Figures 4D,E). Because
we find increased aberrations in daf-2 RNAi coincident with a
period of enhanced function (Figure 4A), we raise the question
Table 3 | RNAi treatments targeting the insulin signaling pathway differentially effect polyQ128 specific mechanosensory neuronal
aberrations.
Specific types of
aberrations per
Cell type RNAi treatment on polyQ128 animals
Empty vector (daf-2 age-1 daf-18 akt-1 daf-16
(Nanterior = 226; Nanterior = 199; (Nanterior = 185; (Nanterior = 92; (Nanterior = 93; (Nanterior = 143;
Nposterior = 217) Nposterior = 202) Nposterior = 185) Nposterior = 94) Nposterior = 92) Nposterior = 140)
Mean ± SE Mean ± SE p-value Mean ± SE p-value Mean ± SE p-value Mean ± SE p-value Mean ± SE p-value
Number of cell
body outgrowths
Anterior 1.11 ± 0.05 0.86 ± 0.04 *0.00 1.32 ± 0.06 *0.01 1.21 ± 0.08 n.s. 1.24 ± 0.08 n.s. 1.29 ± 0.06 *0.03
Posterior 0.01 ± 0.01 0.01 ± 0.03 n.s. 0.03 ± 0.03 n.s. 0.01 ± 0.01 n.s. 0.00 ± 0.00 n.s. 0.01 ± 0.01 n.s.
Number of
branches
Anterior 0.15 ± 0.03 0.09 ± 0.02 *0.05 0.16 ± 0.03 n.s. 0.23 ± 0.05 n.s. 0.10 ± 0.03 n.s. 0.13 ± 0.03 n.s.
Posterior 0.07 ± 0.02 0.05 ± 0.02 n.s. 0.08 ± 0.02 n.s. 0.05 ± 0.02 n.s. 0.03 ± 0.02 n.s. 0.05 ± 0.02 n.s.
Presence of
punctae
Anterior 0.14 ± 0.02 0.04 ± 0.02 *0.00 0.37 ± 0.02 *0.00 0.27 ± 0.03 *0.02 0.39 ± 0.03 *0.00 0.33 ± 0.02 *0.00
Posterior 0.71 ± 0.03 0.90 ± 0.03 *0.00 0.59 ± 0.04 *0.02 0.65 ± 0.05 n.s. 0.55 ± 0.05 *0.01 0.58 ± 0.04 *0.01
Presence of Anterior 0.13 ± 0.01 0.03 ± 0.01 *0.00 0.19 ± 0.01 n.s. 0.10 ± 0.02 n.s. 0.15 ± 0.02 n.s. 0.11 ± 0.01 n.s.
abnormal cell
body
Posterior 0.00 ± 0.01 0.02 ± 0.01 *0.02 0.03 ± 0.01 *0.01 0.02 ± 0.02 n.s. 0.00 ± 0.02 n.s. 0.03 ± 0.01 *0.02
Table depicts mean number and significant difference for anterior (ALML or ALMR) and posterior (PLML or PLMR) mechanosensory neurons following RNAi
treatment for each specific neuronal aberration observed (i.e., cell body outgrowths, process branching, presence of process punctae, and cell body abnormality).
p-values indicate significance compared to appropriate empty vector control following generalized linear model analysis. Sample sizes for anterior (Nanterior ) and
posterior (Nposterior ) neurons of each RNAi treatment are shown. Example outgrowths (A), branching (B), punctae (C), and abnormal cell body (D) are shown in
Figure 4B. *Denotes significance of p < 0.05.
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of whether mid-life branching might be a manifestation of a nor-
mal neuronal defense mechanism that actually improves sensory
capacity, although this issue remains to be resolved with sin-
gle animal functional imaging. This finding is also significant
in that it suggests that all changes in morphology seen with age
or treatments are not the same mechanistically and that some
phenotypes, such as process branching, may be protective to neu-
rons. Differences from other studies (Pan et al., 2011; Tank et al.,
2011; Toth et al., 2012) could arise from differences in methods
for reducing daf-2 expression (with RNAi knockdown being dis-
tinct from modulation of specific amino acid resides in receptor
reduction-of-function mutants) and different timing of scoring
during adult life.
age-1 PI3 kinase and other insulin signaling molecules
We found that age-1 RNAi modestly increased branching of
mechanosensory neuron processes at day 5 of adult life, but did
not alter touch sensitivity. The latter observation establishes that
morphological phenotype and function are not always linked.
akt-1, daf-18, and daf-16 RNAi interventions did not alter the
trajectory of age-associated morphological change in otherwise
healthy neurons. The role of age-1, akt-1, and daf-18 in mor-
phological aging of the mechanosensory neurons has not been
previously reported. Overall, age-1 knockdown can have an effect
on mechanosensory neuron morphological aging (Figures 4D,E)
but impact on function is not large at mid-life. Other pathways
that run in parallel may be important in mid-adult life (Tank
et al., 2011).
daf-16
For natural aging of mechanosensory neurons, we find that
daf-16 RNAi exerts a small but statistically significant effect on
day 5 adult posterior touch response, but not on aberrations.
Tank et al. (2011) also came to the conclusion that aberrations
for day 10 branching in a daf-16 deletion mutant were similar
to wildtype; whereas Pan et al. (2011) and Toth et al. (2012)
noted a small increase in aberrations in daf-16 mutants at days
9 and 10 (note the latter study, like ours, found no change at
adult day 5). Still, time course studies do not support a pro-
found impact of daf-16 disruption on morphological aging of
the mechanosensory neurons. daf-16 appears to be needed for
daf-2(rf)-mediated suppression of excess branching, though cell
autonomy of this activity is disputed (Pan et al., 2011; Tank et al.,
2011).
Overall, although compelling data support that insulin sig-
naling a factor in natural aging of mechanosensory neurons,
with reduced signaling correlating with reduced function, other
pathways likely influence the process as well (Tank et al.,
2011).
DISTINCTIVE OUTCOMES OF daf-2 RNAi IN THE PROTEOTOXICALLY
STRESSED HUNTINGTON’S DISEASE MODEL STRAIN
daf-2
In middle-aged polyQ128 animals, we found that daf-2 RNAi
improved mechanosensory function, limited the number of
morphological aberrations, and decreased overall aggregate num-
ber and size, compared to empty vector controls (Figure 5). Thus,
reduced insulin receptor signaling through DAF-2 confers neuro-
protection that is associated with diminished polyQ128 aggregate
load in this model. Our data are consistent with studies in other
disease models (Cohen et al., 2010) implicating daf-2 in enhanced
proteostasis during toxic protein challenge.
age-1 PI3 kinase and other insulin signaling molecules
We found that age-1 RNAi modestly impairs touch sensitiv-
ity at a time point at which the mean number of aberrations
and of aggregates are elevated relative to empty vector con-
trols (Figure 4). Unexpectedly, akt-1 and daf-16 RNAi, which
should have opposing impacts on the signal transduction path-
way, induce similar outcomes in these proteotoxically challenged
mechanosensory neurons. Because age-1 RNAi [and sometimes
akt-1 (Hertweck et al., 2004)] extend lifespan (Table 2), dysfunc-
tion is not the anticipated outcome of such interventions. We
emphasize two points here: first, our data raise the possibility
that the most commonly outlined downstream pathway for DAF-
2 signaling may not be the operative signaling pathway for the
mechansensory neuron proteotoxicity pathway; and second, as
it has previously been noted that other healthspan phenotypes
differentially affected by daf-2 vs. age-1 mutations. For exam-
ple, in age-1 mutants the biphasic profile for rate of increase in
lipofuscin/age pigments during adulthood shows a temporal shift
(delay in onset without change in time course), whereas for daf-2
mutants the rate of lipofuscin accumulation remains low across
adulthood (Gerstbrein et al., 2005). In other words, daf-2 is more
effective in preventing long term elevation in age pigment accu-
mulation, while age-1 delays onset of accumulation. This anomaly
is a precedent for differential health outcomes following closely
related insulin signaling pathway interventions.
In previous work, Morley et al. (2002) found that C. elegans
expressing polyQ82 in body wall muscle show slower develop-
ment of aggregates and motility defects with age-1 RNAi and
age-1 mutants. While those authors showed the opposite effect of
age-1 RNAi on polyQ accumulation and toxicity compared to our
study using a different cell type, they stressed the importance of
threshold stresses in their interpretation. We note that our model
carries an elevated polyglutamine load (polyQ128) as compared
to polyQ82. In humans, longer polyglutamine expansion in hunt-
ingtin is well known to result in earlier onset of Huntington’s
disease and lower life expectancy.
daf-16
As expected, we observed daf-16 RNAi confers diminished
mechanosensory function together with increased anterior aber-
ration and increased number and size of aggregates. Our results
are consistent with previous studies showing that daf-16 defi-
ciency is associated with exacerbated polyQ128 proteotoxicity
in young adult mechanosensory neurons (Parker et al., 2005,
2012; Lejeune et al., 2012) and with enhanced proteotoxicity in
a polyQ82 model (Morley et al., 2002) and an Alzheimer’s disease
model (Cohen et al., 2009).
Overall, changes in anterior and posterior cell function,
morphology, and protein aggregation load and localization
(Figures 4, 5) correlate with whole animal observations
(Figure 3) in both polyQ0 and polyQ128 strains. However, with
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polyQ128 daf-16 RNAi we observed decreased anterior and
posterior mechanosensory function (Figure 5A) and increased
protein aggregate area and number in whole animal and both
cell types (Figure 5D and Supplemental Figure 2), while only
anterior mechanosensory neurons (ALML or ALMR) increased
significantly in total neuronal aberrations (Figure 5B). This
maintenance of neuronal morphology with worsened function
and protein aggregation suggests other mechanisms can mediate
these endpoints.
daf-2 RNAi UNIQUELY CHANGES DISTRIBUTION OF polYQ128
AGGREGATE LOAD
A striking observation of daf-2 RNAi animals is a profound dif-
ference in the distribution of polyQ128 aggregates (Figures 5E,F).
daf-2 RNAi is the only intervention we tested that induces local-
ization of CFP-labeled polyQ128 aggregates nearly exclusively to
the neuron cell body. Most aggregates we concentrated in only a
few dots, which resembled perinuclear lysosomes. Although this
subcellular domain restriction remains to be definitively identi-
fied, our observations suggest that for both anterior and posterior
mechanosensory neurons, daf-2 may exert neuroprotection by
sequestering aggregates to prevent them from interfering with
other cellular functions. The lower aggregate size suggests that
enhanced degradation may occur when DAF-2 signaling is low.
Our data also suggest that DAF-2 signaling could influence axonal
transport of aggregate proteins or their retention in the cell body.
Since we did not observe the cell body restricted pattern of age-1
RNAi, a non-canonical downstream signaling pathway might be
responsible for the observed effect.
NEURONS AGING UNDER EXTREME AGGREGATE CHALLENGE EXHIBIT
DIFFERENCES FROM NATURAL AGING
It is striking that the daf-2 RNAi polyQ128 neuronal aber-
ration level is below that of polyQ128 empty vector controls
(Figure 5B), and similar to that of polyQ0 empty vector con-
trols (Figure 4C), while polyQ0 daf-2 RNAi increases aberrations.
Together with stresses induced by polyQ128, low insulin signal-
ing (daf-2 and age-1 RNAi treatment) is associated both with
protection from and an increase in morphological restructur-
ing. Without extreme proteotoxic challenge at mid-life (as in
polyQ0), however, neuronal aberrations are more apparent when
insulin signaling is low. One possibility to explain these dif-
ferences between daf-2 RNAi in the naturally aging (polyQ0)
and proteotoxically stressed (polyQ128) models is that hormetic
consequences induced by polyQ128 are involved in suppres-
sion of aberrations. Alternatively, the aberrations in polyQ0 may
be a manifestation of cellular maintenance that cannot be exe-
cuted in the face of extreme polyQ128 challenge. An interesting
question is whether additional neuron classes in the polyQ128
animals are affected by the expression of polyQ aggregates in
the mechanosensory neurons or whether these effects are cell
autonomous.
A second striking difference between natural aging and aging
under extreme proteotoxic stress resides in daf-16 RNAi treat-
ment effects. In polyQ0 animals, daf-16 RNAi impairs posterior
touch sensation, but does not markedly alter neuronal morphol-
ogy (only affecting anterior touch sensitivity). In contrast, in
polyQ128 animals, daf-16 RNAi results in both impaired touch
response and increased neuronal aberrations. Also, daf-16 RNAi
in polyQ128, aggregate load increases and lifespan decreases pro-
portionally more than in polyQ0. This suggests that polyQ128
expression in mechanosensory neurons induces stress signaling
to other body tissues to disrupt the overall health of the animal.
A potential mechanism for the differences in effects of manip-
ulating insulin signaling in polyQ0 and polyQ128 is increased
basal insulin signaling in polyQ128 as a result of its protein
load. However, we propose this is unlikely to be the mech-
anism underlying the observed differences. We see no differ-
ence in lifespan between empty vector control (L4440) treated
polyQ0 and polyQ128 lifespan (Figure 2A). This is not surpris-
ing given that mechanosensory neurons do not seem to modulate
lifespan (Chalfie et al., 1985). Further, microarray analysis of
polyQ128 FACS-purified Pmec-3 cells (mechanosensory neurons)
showed no apparent dysregulation of genes in the insulin signal-
ing pathway compared to non-toxic huntingtin:polyglutamine-
expressing controls (Tourette and Neri, personal communica-
tion). Thus, the differences in neuron morphology and func-
tion seen in empty vector control treated polyQ0 and polyQ128
animals are likely due to some mechanism other than insulin
signaling.
We have seen that with age, the effects on touch response
and mechanosensory morphology are negatively correlated in
polyQ0 and polyQ128 models (Vayndorf et al., in preparation).
We showed that this correlation between increased morpholog-
ical aberrations and decreased function remains in all RNAi
treated polyQ128 animals (Figure 5). However, when polyQ0 ani-
mals receive RNAi treatment targeting components of the insulin
signaling pathway, touch response and accumulation of aber-
rant morphology are no longer negatively correlated (Figure 4).
Interestingly, while only daf-2 RNAi showed overall significant
effects on mechanosensory morphology and function in polyQ0
animals, RNAi treatment of polyQ128 animals yielded a higher
number of significant changes. Also, we observed empty vec-
tor control polyQ128 animals decreased touch response and
increased changes in neuronal morphology when compared
to polyQ0 animals. Perhaps the decreased baseline neuronal
function and worsened baseline neuronal morphology of the
polyQ128 animals makes them more susceptible to changes in
expression of insulin signaling pathway proteins, whereas natu-
rally aging animals have more ability to compensate with other
signaling pathways when there are changes in insulin signaling
protein expression.
Overall, our findings suggest that improving neuronal aging
outcomes and neuronal dysfunction associated with elevated pro-
tein aggregate stress may not be as simple as decreasing classical
insulin signaling. This is not surprising because there are 40
insulin ligands with different expression levels in various cell
types all vying for binding sites at the C. elegans insulin receptor,
DAF-2. Others have shown that this insulin network is com-
plex and works together to respond to varying stresses (Ritter
et al., 2013), including protein misfolding and dysfunction like
in our polyQ128 model. In addition, in mammalian and cell
culture models, huntingtin is a phosphorylation substrate for
AKT/PKB (Humbert et al., 2002; Dong et al., 2012). AKT can be
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modified and even cleaved into an inactive form in a rat model
of Huntington’s disease (Colin et al., 2005). Thus, in systems with
endogenous huntingtin, unlike C. elegans, complex interactions
between insulin signaling, expanded polyglutamine huntingtin
aggregation, and neuronal morphology and function may be
operative. Further genetic studies of the huntingtin polyQ128
model in C. elegans have the potential to elucidate mecha-
nisms that influence morphological changes during neuronal
aging.
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